This 3-day training offered by psychologists Ingmar Gorman and Elizabeth Nielson is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. This interactive training includes role plays, demonstrations, case examples, and experiential learning opportunities.
Your patients are curious and so are you: What is all this about psychedelics being used for treatment of addiction and trauma? This session gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy. The program includes an overview of recent and current clinical trials, outcomes, legal status, and what it all means for the future of addiction and trauma treatment.
We then introduce clinical skills for psychedelic harm reduction and integration work in the clinical setting. We focus on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. Our time includes discussion of assessment and integration techniques, resources, and legal and ethical issues.